Clinical Scorecard: Efficacy of Modified Meridian-Guided Acupoint Pressing in Treating Lumbar Facet Joint Osteoarthritis: Insights from Microbiomics and Metabolomics Approaches

At a Glance

Key Highlights

• MMGAP significantly reduced inflammatory cell infiltration in lumbar muscles/facet joints.
• Downregulated serum IL-1β and TNF-α levels by more than 40%.
• Reshaped gut microbiota and enriched mTOR signaling pathway.
• FMT from MMGAP-treated rats recapitulated therapeutic effects.
• Rapamycin mimicked MMGAP's anti-inflammatory and analgesic actions.

Guideline-Based Recommendations

Diagnosis

• Utilize animal models to study LFJ OA and its mechanisms.

Management

• Consider MMGAP as a non-invasive intervention for LFJ OA.

Monitoring & Follow-up

• Assess inflammatory markers and gut microbiota composition.

Risks

• Current pharmacological interventions may have adverse effects.

Patient & Prescribing Data

Patients with lumbar facet joint osteoarthritis, particularly older adults.

MMGAP may provide a non-invasive alternative to traditional pharmacological treatments.

Clinical Best Practices

• Incorporate MMGAP in treatment plans for LFJ OA.
• Monitor patient responses to MMGAP and adjust as necessary.

Related Resources & Content

• Study on LFJ OA and MMGAP